{"status":"OK","data":{"id":487639,"identifier":"HDB4J6","persistentUrl":"https://doi.org/10.34894/HDB4J6","protocol":"doi","authority":"10.34894","separator":"/","publisher":"DataverseNL","publicationDate":"2025-06-23","storageIdentifier":"surf://10.34894/HDB4J6","effectiveDatasetFileCountLimit":10000,"datasetFileUploadsAvailable":10000,"datasetType":"dataset","locks":[],"latestVersion":{"id":30836,"datasetId":487639,"datasetPersistentId":"doi:10.34894/HDB4J6","datasetType":"dataset","storageIdentifier":"surf://10.34894/HDB4J6","versionNumber":1,"internalVersionNumber":8,"versionMinorNumber":1,"versionState":"RELEASED","latestVersionPublishingState":"RELEASED","deaccessionLink":"","distributionDate":"2025-06-23","productionDate":"2021","lastUpdateTime":"2025-07-15T14:05:24Z","releaseTime":"2025-07-15T14:05:24Z","createTime":"2025-07-10T11:58:25Z","publicationDate":"2025-06-23","citationDate":"2025-06-23","effectiveDatasetFileCountLimit":10000,"datasetFileUploadsAvailable":10000,"license":{"name":"CC0-1.0","uri":"http://creativecommons.org/publicdomain/zero/1.0","iconUri":"https://licensebuttons.net/p/zero/1.0/88x31.png","rightsIdentifier":"CC0-1.0","rightsIdentifierScheme":"SPDX","schemeUri":"https://spdx.org/licenses/","languageCode":"en"},"fileAccessRequest":true,"metadataBlocks":{"citation":{"displayName":"Citation Metadata","name":"citation","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of insufficient immunological memory or sufficient protection against re-infection - a Target to B! substudy"},{"typeName":"subtitle","multiple":false,"typeClass":"primitive","value":"T2B! immunity after SARS-CoV-2"},{"typeName":"alternativeURL","multiple":false,"typeClass":"primitive","value":"https://www.amc.nl/web/research/trials-collaborations/target-to-b-immuniteit-tegen-sars-cov-2-bij-patienten-met-auto-immuun-ziekten.htm"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Wieske, Luuk"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"amsterdamumc.nl"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"van Dam, Koos"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"amsterdamumc.nl"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Eftimov, Filip"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"amsterdamumc.nl"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"Observational, prospective, multicenter study on immunity and immune responses against SARS-CoV-2 in patients with inflammatory disorders"},"dsDescriptionDate":{"typeName":"dsDescriptionDate","multiple":false,"typeClass":"primitive","value":"2025"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"SARS-CoV-2 immunity"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"SARS-CoV-2 in inflammatory disorders"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Immunological memory SARS-CoV-2"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Prospective observational study"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Humoral and cellular immunity"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Multicenter cohort study COVID-19"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"COVID-19 reinfection risk"}}]},{"typeName":"publication","multiple":true,"typeClass":"compound","value":[{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study."},"publicationIDType":{"typeName":"publicationIDType","multiple":false,"typeClass":"controlledVocabulary","value":"pmid"},"publicationIDNumber":{"typeName":"publicationIDNumber","multiple":false,"typeClass":"primitive","value":"35317410"}},{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod"},"publicationIDNumber":{"typeName":"publicationIDNumber","multiple":false,"typeClass":"primitive","value":"PMID: 35523569"}},{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies"},"publicationIDNumber":{"typeName":"publicationIDNumber","multiple":false,"typeClass":"primitive","value":"PMID: 35527808"}},{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273"},"publicationIDNumber":{"typeName":"publicationIDNumber","multiple":false,"typeClass":"primitive","value":"PMID: 35838348"}},{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations"},"publicationIDNumber":{"typeName":"publicationIDNumber","multiple":false,"typeClass":"primitive","value":"PMID: 36621174"}},{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment"},"publicationIDNumber":{"typeName":"publicationIDNumber","multiple":false,"typeClass":"primitive","value":"PMID: 40010153"}}]},{"typeName":"notesText","multiple":false,"typeClass":"primitive","value":"main articles of this project, describing overall methodology related to clinical studies, antibody and cellular studies"},{"typeName":"language","multiple":true,"typeClass":"controlledVocabulary","value":["English"]},{"typeName":"productionDate","multiple":false,"typeClass":"primitive","value":"2021"},{"typeName":"productionPlace","multiple":true,"typeClass":"primitive","value":["Amsterdam UMC, Sanquin and other (univerisity) hospitals"]},{"typeName":"contributor","multiple":true,"typeClass":"compound","value":[{"contributorType":{"typeName":"contributorType","multiple":false,"typeClass":"controlledVocabulary","value":"Project Leader"},"contributorName":{"typeName":"contributorName","multiple":false,"typeClass":"primitive","value":"Eftimov, Filip"}}]},{"typeName":"grantNumber","multiple":true,"typeClass":"compound","value":[{"grantNumberAgency":{"typeName":"grantNumberAgency","multiple":false,"typeClass":"primitive","value":"ZonMw"}}]},{"typeName":"distributionDate","multiple":false,"typeClass":"primitive","value":"2025-06-23"},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Wieske, Luuk"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2025-06-23"},{"typeName":"timePeriodCovered","multiple":true,"typeClass":"compound","value":[{"timePeriodCoveredStart":{"typeName":"timePeriodCoveredStart","multiple":false,"typeClass":"primitive","value":"2021"},"timePeriodCoveredEnd":{"typeName":"timePeriodCoveredEnd","multiple":false,"typeClass":"primitive","value":"2025"}}]},{"typeName":"dateOfCollection","multiple":true,"typeClass":"compound","value":[{"dateOfCollectionStart":{"typeName":"dateOfCollectionStart","multiple":false,"typeClass":"primitive","value":"2021"},"dateOfCollectionEnd":{"typeName":"dateOfCollectionEnd","multiple":false,"typeClass":"primitive","value":"2024"}}]},{"typeName":"kindOfData","multiple":true,"typeClass":"primitive","value":["clinical data","questionnaire data","blood","peripheral blood mononuclear cell"]},{"typeName":"software","multiple":true,"typeClass":"compound","value":[{"softwareName":{"typeName":"softwareName","multiple":false,"typeClass":"primitive","value":"Castor"}},{"softwareName":{"typeName":"softwareName","multiple":false,"typeClass":"primitive","value":"CSV files serology"}},{"softwareName":{"typeName":"softwareName","multiple":false,"typeClass":"primitive","value":"cellular analyses"}}]}]},"dansDataVaultMetadata":{"displayName":"Data Vault Metadata","name":"dansDataVaultMetadata","fields":[{"typeName":"dansDataversePid","multiple":false,"typeClass":"primitive","value":"doi:10.34894/HDB4J6"},{"typeName":"dansDataversePidVersion","multiple":false,"typeClass":"primitive","value":"1.1"},{"typeName":"dansBagId","multiple":false,"typeClass":"primitive","value":"urn:uuid:8220a527-43f5-490d-bdb6-0d74a515ae4f"},{"typeName":"dansNbn","multiple":false,"typeClass":"primitive","value":"urn:nbn:nl:ui:13-6521bc72-ee3a-4a43-9f63-f127f6e53181"}]}},"files":[]}}}